BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/21/2025 7:50:19 AM | Browse: 7 | Download: 0
Category |
Oncology |
Manuscript Type |
Retrospective Study |
Article Title |
Prognostic value of preoperative fibrinogen, neutrophil-to-lymphocyte ratio, serum alpha-fetoprotein, and prealbumin for primary liver cancer undergoing trans-arterial chemoembolization
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Qi-Qi Liu, Ya-Dong Li, Jia-Xin Chen, Lin-Lin Zhang, Rong-Chun Guan, Wei Zhao and Ling-Yu Meng |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Health Commission of Heilongjiang Province |
0230404080031 |
|
Corresponding Author |
Ling-Yu Meng, Clinical Laboratory, The Third Affiliated Hospital of Qiqihar Medical University, No. 3 Taishun Street, Tiefeng District, Qiqihar 161000, Heilongjiang Province, China. 18345202361@163.com |
Key Words |
Primary liver cancer; Trans-arterial arterial chemoembolization; Prognose; Fibrinogen and neutrophil-to-lymphocyte ratio score; Serum alpha-fetoprotein; Prealbumin |
Core Tip |
This study investigates the prognostic value of combining fibrinogen and neutrophil-to-lymphocyte ratio (F-NLR) score, alpha-fetoprotein (AFP), and prealbumin (PA) in patients with primary liver cancer undergoing transarterial chemoembolization. Our findings indicate that integrating F-NLR, which reflects systemic inflammation and coagulation status, AFP as a marker of tumor burden, and PA as an indicator of nutritional status and liver function, significantly enhances prognostic accuracy. This combined approach provides a basis for personalized treatment strategies, enabling precise identification of high-risk patients and optimizing therapeutic plans to improve outcomes. |
Citation |
Liu QQ, Li YD, Chen JX, Zhang LL, Guan RC, Zhao W, Meng LY. Prognostic value of preoperative fibrinogen, neutrophil-to-lymphocyte ratio, serum alpha-fetoprotein, and prealbumin for primary liver cancer undergoing trans-arterial chemoembolization. World J Gastrointest Oncol 2025; In press |
 |
Received |
|
2025-02-18 08:28 |
 |
Peer-Review Started |
|
2025-02-18 08:28 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-03-06 07:08 |
 |
Revised |
|
2025-03-21 09:17 |
 |
Second Decision |
|
2025-04-21 02:38 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-04-21 07:50 |
 |
Articles in Press |
|
2025-04-21 07:50 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2025-04-26 00:56 |
 |
Typeset the Manuscript |
|
|
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345